BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
123 hedge funds and large institutions have $1.37B invested in Audentes Therapeutics, Inc in 2018 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 34 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 114 → 123 (+9)
40% less call options, than puts
Call options by funds: $2.5M | Put options by funds: $4.19M
Holders
123
Holding in Top 10
3
Calls
$2.5M
Puts
$4.19M
Top Buyers
| 1 | +$35.2M | |
| 2 | +$20.1M | |
| 3 | +$19.4M | |
| 4 |
BlackRock
New York
|
+$19M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$16.3M |
Top Sellers
| 1 | -$34.7M | |
| 2 | -$31.2M | |
| 3 | -$26.9M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$17.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$15.1M |